Sy Mukherjee, Fortune

Sy Mukherjee


New York, NY, United States

Contact Sy

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Fortune

Recent articles by Sy:

Brainstorm Health: Verily Eye Scans, Organs on Chips, Merck-Viralytics Deal

Hello, readers! This is Sy. Google parent Alphabet’s life sciences arm Verily—the firm running an ambitious study to map a “baseline” of human health—may have an intriguing new way to assess heart disease risk: Through your eyes. As with pretty much all things Verily, the method is centered on machine learning, as detailed in a report published in the journal Nature Biomedical Engineering. The… → Read More

Brainstorm Health: Roche Buys Flatiron, FDA Alzheimer's Guidance, Flu Vaccine Effectiveness

Hello and happy Friday, readers! This is Sy. The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1.9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health analytics upstart that’s attempting to use real world patient information and big data to spur better oncology R&D. Flatiron’s cancer-centric electronic… → Read More

Guns Are a Huge Reason Americans Die Younger Than People In Similar Countries

Gun violence in the U.S. is a major reason that America has so many premature deaths and disability compared with similar countries. → Read More

This Year's Flu Vaccine Is Only 36% Effective. Why You Should Still Get It

It's still not too late to get vaccinated during this horrible flu season. → Read More

Why Drug Giant Roche's $1.9 Billion Deal to Buy Data Startup Flatiron Health Matters

Flatiron is connected with hundreds of cancer treatment centers—and its data collection could spur new drugs. → Read More

The FDA Just Approved a Blood Test for Concussions

The FDA approved Banyan Biomarkers' blood test for concussion. The concussion blood test is the latest evolution in medical diagnostics. → Read More

Brainstorm Health: Joseph Swedish to Proteus, Bristol-Myers Deal, Idaho Vs. Obamacare

Hey there and happy hump day, readers! This is Sy. Going to keep this one short and sweet—some intriguing developments on both the policy and business sides today. For one, Proteus Digital Health, the company that won approval for the first-ever “digital pill,” is adding a big name to its roster; and, on the policy end, Idaho is about to set up a critical battle over Obamacare, federalism, and… → Read More

These DNA 'Nanobots' Could Help Kill Cancer By Choking Off Its Life Blood

Scientists have found that engineered DNA "nanobots" can choke off cancerous tumors' blood supply in mice—a big potential advance in cancer. → Read More

Brainstorm Health: Cancer Nanorobots, American Well-Being, Former Celgene CEO's Senate Run

Hello, readers! This is Sy. The cancer treatment space has given way to some extraordinary advances in recent years, including therapies that can re-engineer your own cells to fight cancer. But, according to a paper published in the journal Nature Biotechnology, scientists may be on the cusp of yet another significant milestone—tiny little cancer-killing robots that choke off the blood supply to… → Read More

This Company Wants to Sequence Your Genome, Put It On a Blockchain—And Pay You For It

Nebula Genomics has an ambitious plan to fuel drug development while preserving genetic data security. → Read More

Brainstorm Health: Genome on a Blockchain, Budget Deal, U.S. Life Expectancy Drop

Hello and happy Friday, readers! This is Sy. Blockchain and cryptocurrency mania has engulfed the Internet in the past year. But could the digital ledger tech (and its offshoot applications) also help spur drug development, ensure genetic privacy, and make consumers some crypto-money on the side—all in one fell swoop? That’s the ambitious quest driving Nebula Genomics, a company founded and… → Read More

This GV-Backed Company Thinks Its "Robotic Pill" Could Replace Painful Drug Injections

Companies including Google venture arm GV are backing Rani Therapeutics, which is working on a "robotic pill" to replace injections. → Read More

Brainstorm Health: Robotic Pills, Gilead Vs Glaxo, Federal Spending Bill and Health Care

Hey there, readers! This is Sy. Sometimes, it can be a pain, literally, to take prescription medication—especially when that medication has to be administered via injection. But injections are the most effective (or at least the most preferred) form of drug delivery for certain kinds of treatments, including those for chronic conditions like diabetes, psoriasis, arthritis, and others. But what… → Read More

Brainstorm Health: New Zealand's HIV Prevention Plan, Apple Watch Diabetes Study, FDA Vs Kratom

Hello and happy hump day, readers! This is Sy. New Zealand is about to take a pioneering approach to fighting HIV/AIDS—by publicly funding pre-exposure prophylaxis (PrEP) medication Truvada, manufactured by U.S. biotech giant Gilead. Taking this drug daily has shown to offer more than 90% (and as much as 99%) effective protection against HIV in clinical trials, and certain New Zealand residents… → Read More

America's Richest and Most Controversial Doctor Is Buying the 'Los Angeles Times'

Patrick Soon-Shiong is a doctor-turned-biotech billionaire—and has faced some heavy criticism. → Read More

Former GE CEO Jeff Immelt Was Just Appointed Chairman of This Digital Health Company

Athenahealth has appointed Jeff Immelt in a high-profile pickup for the cloud-based medical records firm. → Read More

New Zealand Is About to Make the Revolutionary HIV Prevention Drug Truvada Almost Free

The PrEP drug will be publicly funded in New Zealand for those at high risk for HIV infection. → Read More

The Diseases We Aren't Curing—And Why

Drug makers are flocking to certain treatment types. Why do others get left behind? → Read More

Psychologists Explain Why Some Eagles Fans Rioted After Winning the Super Bowl

Biology and social identity help explain why Super Bowl-winning fans celebrate irresponsibly. → Read More

Brainstorm Health: The Science of Super Bowl Riots, Intarcia Setback, Sanofi Dengue Lawsuit

If you know someone who’s even tangentially connected to Philadelphia (or who, well, just really hates Tom Brady and Bill Belichick), you probably heard a rendition or 12 of the “Fly Eagles Fly” chant last night as the Eagles beat the New England Patriots in a wildly entertaining Super Bowl stunner. Unfortunately for local Philadelphia authorities, not to mention municipal and private property… → Read More